Tango Therapeutics, Inc. (TNGX)
25.76
-0.11
(-0.43%)
USD |
NASDAQ |
Apr 24, 16:00
25.65
-0.11
(-0.43%)
After-Hours: 20:00
Tango Therapeutics Shareholders Equity (Quarterly) : 346.18M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 1.631B |
| Kodiak Sciences, Inc. | 157.38M |
| Hims & Hers Health, Inc. | 540.93M |
| Recursion Pharmaceuticals, Inc. | 1.131B |
| Terns Pharmaceuticals, Inc. | 1.007B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 410.01M |
| Total Liabilities (Quarterly) | 63.83M |
| Debt to Equity Ratio | 0.097 |
| Current Ratio | 16.32 |
| Net Debt Paydown Yield | 0.07% |